These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1281204)
21. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats. Kruse P; Lasson A; Hage E J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332 [TBL] [Abstract][Full Text] [Related]
22. Effect of ethanol on pancreatic lysosomes in rats: a possible mechanism for alcoholic pancreatitis. Hirano T; Manabe T Nihon Geka Hokan; 1993 Jan; 62(1):16-23. PubMed ID: 8352636 [TBL] [Abstract][Full Text] [Related]
24. Sodium arsenite induces heat shock protein 70 expression and protects against secretagogue-induced trypsinogen and NF-kappaB activation. Bhagat L; Singh VP; Dawra RK; Saluja AK J Cell Physiol; 2008 Apr; 215(1):37-46. PubMed ID: 17941083 [TBL] [Abstract][Full Text] [Related]
25. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis. Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771 [TBL] [Abstract][Full Text] [Related]
26. Ghrelin attenuates the development of acute pancreatitis in rat. Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611 [TBL] [Abstract][Full Text] [Related]
27. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats. Hirano T; Manabe T; Tobe T Dig Dis Sci; 1993 Apr; 38(4):660-4. PubMed ID: 7681748 [TBL] [Abstract][Full Text] [Related]
28. Secretion of lysosomal and digestive enzymes into pancreatic juice under physiological and pathological conditions in rabbits. Hirano T; Manabe T; Printz H; Saluja A; Steer M Nihon Geka Hokan; 1992 Mar; 61(2):103-24. PubMed ID: 1382403 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis]. Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233 [TBL] [Abstract][Full Text] [Related]
30. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis. Van Acker GJ; Weiss E; Steer ML; Perides G Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1738-46. PubMed ID: 17332471 [TBL] [Abstract][Full Text] [Related]
31. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Yoneda M; Goto M; Nakamura K; Shimada T; Hiraishi H; Terano A; Haneda M Regul Pept; 2005 Feb; 125(1-3):119-24. PubMed ID: 15582722 [TBL] [Abstract][Full Text] [Related]
32. Enterokinase induces severe necrosis and rapid mortality in cerulein pancreatitis: characterization of a novel noninvasive rat model of necro-hemorrhagic pancreatitis. Hartwig W; Kolvenbach M; Hackert T; Fortunato F; Schneider L; Büchler MW; Werner J Surgery; 2007 Sep; 142(3):327-36. PubMed ID: 17723883 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation]. Tsukagoshi S Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450 [TBL] [Abstract][Full Text] [Related]
34. Effect of short-termed pancreatic duct obstruction on the pancreatic subcellular organellar fragility and pancreatic lysosomal enzyme secretion in rabbits. Hirano T; Manabe T Scand J Clin Lab Invest; 1992 Oct; 52(6):523-35. PubMed ID: 1384108 [TBL] [Abstract][Full Text] [Related]
35. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat. Wisner JR; Ozawa S; Renner IG Int J Pancreatol; 1989 May; 4(4):383-90. PubMed ID: 2732529 [TBL] [Abstract][Full Text] [Related]
36. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415 [TBL] [Abstract][Full Text] [Related]
37. Regulating effects of arsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats. Xue DB; Zhang WH; Yun XG; Song C; Zheng B; Shi XY; Wang HY Chin Med J (Engl); 2007 Apr; 120(8):690-5. PubMed ID: 17517186 [TBL] [Abstract][Full Text] [Related]
38. Cellular alterations of parotid gland of rats with acute pancreatitis induced by cerulein. Hirano T; Manabe T; Tobe T Int J Pancreatol; 1991; 10(3-4):217-27. PubMed ID: 1724007 [TBL] [Abstract][Full Text] [Related]
39. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307]. Hirano T; Yotsumoto TM; Ando K; Tobe T Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453 [TBL] [Abstract][Full Text] [Related]
40. Prevention by prostaglandins of caerulein-induced pancreatitis in rats. Robert A; Lum JT; Lancaster C; Olafsson AS; Kolbasa KP; Nezamis JE Lab Invest; 1989 May; 60(5):677-91. PubMed ID: 2469859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]